Integrative Sequencing In Germline and Hereditary Tumours

Clinical trial NCT03857594 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03857594
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Hereditary Cancer Syndrome High-Risk Mutation Germline Mutation

Start date: 2018-10-02
Primary completion: 2026-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.